Khuchtumur Bum‐Erdene

This researcher studies galectins, a family of sugar-binding proteins involved in cancer biology, and works to design small molecules that block them. A major focus is developing selective inhibitors of galectin-3 and galectin-1 as potential treatments for cancers such as acute lymphoblastic leukemia, often combining structural biology and computational drug design. The work bridges immunology, protein chemistry, and medicinal chemistry.

Publication output has been fairly steady but modest over the past decade, averaging around two to three papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Typically publishes in teams of ~11 · 0% small-team papers (≤3 authors) · across 5 venues